A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease

2020 ◽  
Vol 35 (7) ◽  
pp. 1249-1253 ◽  
Author(s):  
Nurit Omer ◽  
Nir Giladi ◽  
Tanya Gurevich ◽  
Anat Bar‐Shira ◽  
Mali Gana‐Weisz ◽  
...  
2009 ◽  
Vol 15 (3) ◽  
pp. 242-244 ◽  
Author(s):  
Anna De Rosa ◽  
Chiara Criscuolo ◽  
Pietro Mancini ◽  
Marina De Martino ◽  
Ilaria Anna Giordano ◽  
...  

2009 ◽  
Vol 15 (3) ◽  
pp. 175-180 ◽  
Author(s):  
Biswanath Patra ◽  
Azemat J. Parsian ◽  
Brad A. Racette ◽  
Jing Hua Zhao ◽  
Joel S. Perlmutter ◽  
...  

2014 ◽  
Vol 72 (5) ◽  
pp. 356-359 ◽  
Author(s):  
Hsin Fen Chien ◽  
Tamires Rocha Figueiredo ◽  
Marianna Almeida Hollaender ◽  
Fabiano Tofoli ◽  
Leonel Takao Takada ◽  
...  

Mutations in the LRRK2 gene, predominantly G2019S, have been reported in individuals with autosomal dominant inheritance and sporadic Parkinson’s disease (PD). The G2019S mutation has an age-dependent penetrance and evidence shows common ancestry. The clinical manifestations are indistinguishable from idiopathic PD. Its prevalence varies according to the population studied ranging from less than 0.1% in Asians to 41% in North African Arabs. This study aimed to identify G2019S mutation in Brazilian idiopathic PD patients.Method:We sampled 100 PD patients and 100 age- and gender-matched controls. Genetical analysis was accomplished by polymerase chain reaction (PCR).Results:No G2019S mutations were found in both patients with sporadic PD and controls.Conclusions:Our results may be explained by the relatively small sample size.


Author(s):  
Jin-Whan Cho ◽  
Sung-Yeon Kim ◽  
Sung-Sup Park ◽  
Han-Jun Kim ◽  
Tae-Beom Ahn ◽  
...  

Background:A number of causative mutations such as a-synuclein, parkin, UCHL1, Pink-1, DJ-1 have been identified in Parkinson's disease (PD). They are usually found in the familial cases. One mutation of great interest is the G2019S mutation in the LRRK2 gene, which has been reported in both familial and sporadic PD. Its prevalence has been reported to vary markedly among different races. We examined the prevalence of the G2019S mutation in the Korean PD population for genetic study planning.Methods:We conducted a genetic analysis of the G2019S mutation by standard PCR and restriction digestion method. 453 PD patients were studied, 34% of whom had an age at onset of <50 years and 3.8% had a positive family history.Results:None of the 453 study subjects carried the G2019S mutation.Conclusion:Our result confirms previous reports that the G2019S mutation is rare among PD patients in the Asian population. This result supports the notion that the prevalence of this LRRK2 mutation is population specific, and that there may be a founder effect within western populations.


Author(s):  
D. A. Grimes ◽  
L. Racacho ◽  
F. Han ◽  
M. Panisset ◽  
D. E. Bulman

Background:Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have become the most common known cause for developing Parkinson's disease. The frequency of mutations described in the literature varies widely depending on the population studied with most reports focusing only on screening for the most common G2019S mutation in exon 41.Methods:In this study seven exons (19, 24, 25, 31, 35, 38, and 41) in LRRK2 where mutations have been reported were screened in 230 unselected Parkinson's disease patients using denaturing high-performance liquid chromatography.Results:The sequencing of samples with heteroduplex profiles revealed five novel and two known intronic sequence variants. In our cohort, we were unable to detect any of the known mutations in these exons or identify novel mutations within the LRRK2 gene.Conclusions:Therefore, despite the availability of diagnostic LRRK2 genetic testing it is unlikely to yield a positive result in this population.


2020 ◽  
Author(s):  
Vibeke Devold Valderhaug ◽  
Ola Huse Ramstad ◽  
Rosanne van de Wijdeven ◽  
Kristine Heiney ◽  
Stefano Nichele ◽  
...  

AbstractMutations in the LRRK2 gene have been widely linked to Parkinson’s disease. The G2019S variant has been shown to contribute uniquely to both familial and sporadic forms of the disease. LRRK2-related mutations have been extensively studied, yet the wide variety of cellular and network events directly or indirectly related to these mutations remain poorly understood. In this study, we structured multi-nodal human neural networks carrying the G2019S mutation using custom-designed microfluidic chips coupled to microelectrode-arrays. By applying live imaging approaches, immunocytochemistry and computational modelling, we have revealed alterations in both the structure and function of the resulting neural networks when compared to controls. We provide first evidence of increased neuritic density associated with the G2019S LRRK2 mutation, while previous studies have found either a strong decrease, or no change, compared to controls. Additionally, we corroborate previous findings regarding increased baseline network activity compared to control neural networks. Furthermore, we can reveal additional network alterations attributable to the specific mutation by selectively inducing transient overexcitation to confined parts of the structured multi-nodal networks. These alterations, which we were able to capture both at the micro- and mesoscale manifested as differences in relative network activity and correlation, as well as in mitochondria activation, neuritic remodelling, and synaptic alterations. Our study thus provides important new insights into early signs of neural network pathology significantly expanding upon the current knowledge relating to the G2019S Parkinson’s disease mutation.


2005 ◽  
Vol 57 (6) ◽  
pp. 933-934 ◽  
Author(s):  
Hao Deng ◽  
Weidong Le ◽  
Yi Guo ◽  
Christine B. Hunter ◽  
Wenjie Xie ◽  
...  

2006 ◽  
Vol 21 (8) ◽  
pp. 1232-1235 ◽  
Author(s):  
Roberta Marongiu ◽  
Daniele Ghezzi ◽  
Tamara Ialongo ◽  
Francesco Soleti ◽  
Antonio Elia ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document